Brittny N. Tillman, M. Yanik, A. Birkeland, C. Liu, D. Hovelson, A. Cani, N. Palanisamy, Shannon Carskadon, T. Carey, C. Bradford, S. Tomlins, J. Mchugh, M. Spector, J. Brenner
{"title":"根据靶向测序，成纤维细胞生长因子家族畸变可能是流行病学上低风险患者头颈部鳞状细胞癌的驱动因素","authors":"Brittny N. Tillman, M. Yanik, A. Birkeland, C. Liu, D. Hovelson, A. Cani, N. Palanisamy, Shannon Carskadon, T. Carey, C. Bradford, S. Tomlins, J. Mchugh, M. Spector, J. Brenner","doi":"10.1002/hed.24292","DOIUrl":null,"url":null,"abstract":"Targeted sequencing of patients with epidemiologically low‐risk (ELR) head and neck squamous cell carcinoma (HNSCC) could help identify novel drivers or lost suppressors leading to precision medicine protocols and improved survival rates.","PeriodicalId":75895,"journal":{"name":"Head & neck surgery","volume":"41 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"27","resultStr":"{\"title\":\"Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low‐risk patient as defined by targeted sequencing\",\"authors\":\"Brittny N. Tillman, M. Yanik, A. Birkeland, C. Liu, D. Hovelson, A. Cani, N. Palanisamy, Shannon Carskadon, T. Carey, C. Bradford, S. Tomlins, J. Mchugh, M. Spector, J. Brenner\",\"doi\":\"10.1002/hed.24292\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Targeted sequencing of patients with epidemiologically low‐risk (ELR) head and neck squamous cell carcinoma (HNSCC) could help identify novel drivers or lost suppressors leading to precision medicine protocols and improved survival rates.\",\"PeriodicalId\":75895,\"journal\":{\"name\":\"Head & neck surgery\",\"volume\":\"41 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"27\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Head & neck surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/hed.24292\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Head & neck surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/hed.24292","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low‐risk patient as defined by targeted sequencing
Targeted sequencing of patients with epidemiologically low‐risk (ELR) head and neck squamous cell carcinoma (HNSCC) could help identify novel drivers or lost suppressors leading to precision medicine protocols and improved survival rates.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
